IN8bio Inc. (INAB) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for IN8bio Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$1.02
+6.25% today
Market cap
$9M
Overall quality
—
Kronos AI 30-day
—
IN8bio Inc. (INAB) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $9M. It trades at $1.02, up 6.25% today. 2 analysts' average target of $5.50 implies +439.2% from today's price.
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $5.50 |
| Low – high | $5.00 – $6.00 |
| Analysts | 2 |
| Upside to average | +439.2% |
Kronos AI 30-day forecast
No forecast for this listing.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.